RecruitingEN originalLung cancer

Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Current oncological treatment for patients with locally advanced lung cancer comprise adjuvant immunotherapy (immune checkpoint inhibitors-ICI) as an additional one-year treatment after chemoradiotherapy which increases overall survival and progression-free survival. Patients with lung cancer have a high burden of distressful symptoms at diagnosis and during chemoradiotherapy. Side-effects from immunotherapy differs, they are unspecific and may develop at any point during treatment. However, it is not investigated thoroughly during adjuvant treatment in locally advanced lung cancer. As new oncological treatments are being introduced, focus must be placed on patients quality of life and how patients endure treatment to be able to know how to best support patients during this treatment. The knowledge gained from this project include how adjuvant immunotherapy treatment impacts health. This knowledge is sparse due to the novelty of the treatment.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Rozpoznany zaawansowany rak płuca (nie drobnokomórkowy)
  • •Wiek 18 lat lub więcej
  • •Planowane leczenie chemio- i radioterapią razem z immunoterapią przez 12 miesięcy
  • •Leczenie w jednym z dwóch specjalistycznych ośrodków onkologicznych
  • •Dobry ogólny stan zdrowia (skala wydolności 0-2)

✗ Disqualifies

  • •Inne choroby mogące znacząco wpłynąć na wyniki badania
  • •Brak wystarczającej znajomości języka szwedzkiego utrudniającej zgodę na uczestnictwo

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 2, 2026
Sex
No restrictions

Locations (1)

Department of Oncology, Sahlgrenska University Hospital

Gothenburg, Sweden

Trial contact

Sofie Jakobsson, Associated professor

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.